新型气道平滑肌-肥大细胞交互及TRPV4-ATP轴在非特应性哮喘中的作用
本研究探讨非IgE依赖的肥大细胞-气道平滑肌交互在TRPV4诱导支气管痉挛中的作用。在豚鼠体内及人和豚鼠气道组织中,TRPV4激动剂引起收缩,该效应依赖肥大细胞及ATP激活P2X4受体释放半胱氨酰白三烯,提示TRPV4-ATP轴是非特应性哮喘的潜在驱动因素。
要点
- TRPV4激活气道平滑肌细胞增加钙内流并释放ATP,但不直接引起收缩。
- ATP通过P2X4受体激活肥大细胞释放半胱氨酰白三烯,进而导致气道平滑肌收缩。
- 该通路不依赖IgE,可能解释非特应性哮喘的支气管痉挛机制。
核心结论
- TRPV4激活增加气道平滑肌细胞内钙并释放ATP,触发肥大细胞P2X4依赖的半胱氨酰白三烯释放,导致气道平滑肌收缩。
- 本研究阐明了一种新型肥大细胞-气道平滑肌交互,TRPV4是非IgE依赖、肥大细胞依赖性支气管痉挛的驱动因素。
研究设计与样本
- 研究在麻醉豚鼠体内测量支气管收缩,并采用等长张力测量评估人和豚鼠气道组织收缩。
- 使用FURA2钙敏染料成像检测细胞内钙升高,并利用延时定量相位成像作为气道平滑肌细胞收缩的替代指标。
主要发现
- TRPV4激动剂GSK1016790A在豚鼠体内及人和豚鼠气管组织中引起收缩,该效应被TRPV4拮抗剂GSK2193874抑制。
- GSK1016790A增加人气道平滑肌细胞内钙并释放ATP,但不引起收缩。
- TRPV4和ATP在离体气管组织中诱发收缩,共培养实验表明需要人肺肥大细胞参与。
- 表达谱分析和药理学研究表明肥大细胞激活依赖于ATP激活P2X4受体。
- 胰蛋白酶通过激活PAR-2-TRPV4-ATP-cysLT轴诱发气管组织收缩,提示该信号通路具有疾病相关性。
临床怎么用
- TRPV4-ATP-P2X4-半胱氨酰白三烯轴可能为非特应性哮喘提供新的治疗靶点。
- 针对肥大细胞-气道平滑肌交互的干预或可补充现有IgE靶向治疗的不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mast cell-airway smooth muscle (ASM) interactions play a major role in the immunoglobulin (Ig)E- dependent bronchoconstriction seen in asthma but less is known about IgE-independent mechanisms of mast cell activation. Transient receptor potential cation channel, subfamily V, member 4 (TRPV4) activation causes contraction of human ASM via the release of cysteinyl leukotrienes (cysLTs) but the mechanism is unknown. The objective of the present study was to investigate a role for IgE-independent, mast cell-ASM interaction in TRPV4-induced bronchospasm.Bronchoconstriction was measured in anaesthetised guinea pigs and contraction of human and guinea-pig airway tissue assessed using isometric tension measurements. Increases in intracellular [Ca2+] were imaged using the Ca2+-sensitive dye FURA2, and time-lapse ptychography was utilised as a surrogate for contraction of ASM cells.The TRPV4 agonist GSK1016790A caused contraction in vivo in the guinea pig, and in human and guinea-pig tracheal tissue, which was inhibited by the TRPV4 antagonist GSK2193874. GSK1016790A increased [Ca2+]i and released ATP in human ASM cells without causing contraction. TRPV4 and ATP evoked contraction in isolated tracheal tissue but co-culture experiments indicated a requirement for human lung mast cells. Expression profiling and pharmacological studies demonstrated that mast cell activation was dependent upon ATP activating the P2X4 receptor. Trypsin was shown to evoke contraction of tracheal tissue via activation of PAR-2-TRPV4-ATP-cysLT axis indicating the potential disease relevance of this signalling pathway.TRPV4 activation increases [Ca2+]i and releases ATP from ASM cells triggering P2X4-dependent release of cysLTs from mast cells resulting in ASM contraction. This study delineates a novel mast cell-ASM interaction and TRPV4 as a driver of IgE-independent mast cell-dependent bronchospasm.
引用
- Bonvini SJ, Birrell MA, Dubuis E, et al. Novel airway smooth muscle-mast cell interactions and a role for the TRPV4-ATP axis in non-atopic asthma. Eur Respir J. 2020. PMID: 32299856. doi:10.1183/13993003.01458-2019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。